Загрузка...
Liraglutide compromises pancreatic beta cell function in a humanized mouse model
Incretin mimetics are frequently used in the treatment of type 2 diabetes because they potentiate beta-cell response to glucose. Clinical evidence showing short-term benefits of such therapeutics (e.g., liraglutide) is abundant, however, there have been several recent reports of unexpected complicat...
Сохранить в:
| Опубликовано в: : | Cell Metab |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4785083/ https://ncbi.nlm.nih.gov/pubmed/26876561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2016.01.009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|